Newborn screening guidelines for cystic fibrosis recommend comprehensive genetic testing to ensure timely diagnosis across ...

MONDAY, April 14, 2025 (HealthDay News) -- Current newborn screening for cystic fibrosis favors white children over those ...

A new 96-week study confirms the long-term safety and sustained efficacy of elexacaftor/tezacaftor/ivacaftor in children with cystic fibrosis aged 6–11 years.

While many of the patients that come through the UCSF Fresno Cystic Fibrosis Center are still young, they have transitioned ...

A 47-year-old man with cystic fibrosis hopes that stories like his will be reassuring to younger people diagnosed with the ...

MONDAY, April 14, 2025 (HealthDay News) -- Current newborn screening for cystic fibrosis favors white children over those from other racial and ethnic backgrounds, researchers report. Cystic ...